Foteini Kousathana
Athens, ESYE31 15772, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Effects of Liraglutide, Empagliflozin and Their Combination on Left Atrial Strain and Arterial Function.
Journal: Medicina (Kaunas, Lithuania)
Published: November 01, 2023
Familial Partial Lipodystrophy: Clinical Features, Genetics and Treatment in a Greek Referral Center.
Journal: International journal of molecular sciences
Published: July 07, 2023
Endothelial Dysfunction Is Associated with Decreased Nitric Oxide Bioavailability in Dysglycaemic Subjects and First-Degree Relatives of Type 2 Diabetic Patients.
Journal: Journal of clinical medicine
Published: May 02, 2022
Impaired Endothelial Glycocalyx Predicts Adverse Outcome in Subjects Without Overt Cardiovascular Disease: a 6-Year Follow-up Study.
Journal: Journal of cardiovascular translational research
Published: August 03, 2021
Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes.
Journal: Antioxidants (Basel, Switzerland)
Published: July 20, 2021
Echocardiography, an Indispensable Tool for the Management of Diabetics, with or without Coronary Artery Disease, in Clinical Practice.
Journal: Medicina (Kaunas, Lithuania)
Published: November 25, 2020
The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-year prospective observational study.
Journal: BMC endocrine disorders
Published: November 10, 2020
Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes.
Journal: American journal of physiology. Endocrinology and metabolism
Published: May 28, 2020
Pre-Existing Cytokine and NLRP3 Inflammasome Activation and Increased Vascular Permeability in Diabetes: A Possible Fatal Link With Worst COVID-19 Infection Outcomes?
Journal: Frontiers in immunology
Published: May 19, 2020
Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12-Month Treatment.
Journal: Journal of the American Heart Association
Published: April 25, 2020
β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease.
Journal: Journal of thrombosis and thrombolysis
Published: February 14, 2020
Effects of Different Antidiabetic Medications on Endothelial Glycocalyx, Myocardial Function, and Vascular Function in Type 2 Diabetic Patients: One Year Follow-Up Study.
Journal: Journal of clinical medicine
Published: May 24, 2019
Last Updated: 09/26/2026